US20180044817A1 - Multi-layered microfibers and use thereof - Google Patents
Multi-layered microfibers and use thereof Download PDFInfo
- Publication number
- US20180044817A1 US20180044817A1 US15/558,238 US201615558238A US2018044817A1 US 20180044817 A1 US20180044817 A1 US 20180044817A1 US 201615558238 A US201615558238 A US 201615558238A US 2018044817 A1 US2018044817 A1 US 2018044817A1
- Authority
- US
- United States
- Prior art keywords
- poly
- microfiber
- layer
- polymeric solution
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001410 Microfiber Polymers 0.000 title claims abstract description 111
- 239000003658 microfiber Substances 0.000 title claims abstract description 111
- 238000000034 method Methods 0.000 claims abstract description 35
- -1 poly(vinylidenefluoride) Polymers 0.000 claims description 141
- 229920000642 polymer Polymers 0.000 claims description 45
- 229920003169 water-soluble polymer Polymers 0.000 claims description 31
- 239000002904 solvent Substances 0.000 claims description 27
- 229920001223 polyethylene glycol Polymers 0.000 claims description 22
- 229920001577 copolymer Polymers 0.000 claims description 20
- 229920001661 Chitosan Polymers 0.000 claims description 18
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 16
- 229940072056 alginate Drugs 0.000 claims description 16
- 229920000615 alginic acid Polymers 0.000 claims description 16
- 235000010443 alginic acid Nutrition 0.000 claims description 16
- 238000001523 electrospinning Methods 0.000 claims description 16
- 229920002125 Sokalan® Polymers 0.000 claims description 12
- 229920005615 natural polymer Polymers 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 11
- 229920002472 Starch Polymers 0.000 claims description 11
- 229920002674 hyaluronan Polymers 0.000 claims description 11
- 229960003160 hyaluronic acid Drugs 0.000 claims description 11
- 229920001610 polycaprolactone Polymers 0.000 claims description 11
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 11
- 235000019698 starch Nutrition 0.000 claims description 11
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 10
- 239000008107 starch Substances 0.000 claims description 10
- 229920001059 synthetic polymer Polymers 0.000 claims description 10
- 102000009027 Albumins Human genes 0.000 claims description 9
- 108010088751 Albumins Proteins 0.000 claims description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 9
- 102000008186 Collagen Human genes 0.000 claims description 8
- 108010035532 Collagen Proteins 0.000 claims description 8
- 229920000954 Polyglycolide Polymers 0.000 claims description 8
- 229920001436 collagen Polymers 0.000 claims description 8
- 229920002732 Polyanhydride Polymers 0.000 claims description 7
- 230000003833 cell viability Effects 0.000 claims description 7
- 235000015097 nutrients Nutrition 0.000 claims description 7
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 7
- 229920002307 Dextran Polymers 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 229920001273 Polyhydroxy acid Polymers 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 6
- 239000004952 Polyamide Substances 0.000 claims description 5
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 claims description 5
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 5
- 229920002647 polyamide Polymers 0.000 claims description 5
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 5
- 229920001710 Polyorthoester Polymers 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 3
- 229920001054 Poly(ethylene‐co‐vinyl acetate) Polymers 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 239000002519 antifouling agent Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229940045110 chitosan Drugs 0.000 claims description 3
- 229960002086 dextran Drugs 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 239000003102 growth factor Substances 0.000 claims description 3
- 239000005556 hormone Substances 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 229920003227 poly(N-vinyl carbazole) Polymers 0.000 claims description 3
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 3
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 claims description 3
- 239000002745 poly(ortho ester) Substances 0.000 claims description 3
- 229920002401 polyacrylamide Polymers 0.000 claims description 3
- 229920002239 polyacrylonitrile Polymers 0.000 claims description 3
- 229920000767 polyaniline Polymers 0.000 claims description 3
- 229920000903 polyhydroxyalkanoate Polymers 0.000 claims description 3
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 239000011118 polyvinyl acetate Substances 0.000 claims description 3
- 229920002689 polyvinyl acetate Polymers 0.000 claims description 3
- 230000035939 shock Effects 0.000 claims description 3
- 229940032147 starch Drugs 0.000 claims description 3
- 229920003170 water-soluble synthetic polymer Polymers 0.000 claims description 3
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims description 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 claims description 2
- 229960002796 polystyrene sulfonate Drugs 0.000 claims description 2
- 239000011970 polystyrene sulfonate Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 19
- 239000000243 solution Substances 0.000 description 101
- 210000004027 cell Anatomy 0.000 description 66
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 24
- 239000002202 Polyethylene glycol Substances 0.000 description 17
- 239000011148 porous material Substances 0.000 description 16
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 9
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 9
- 239000000835 fiber Substances 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 8
- 239000004632 polycaprolactone Substances 0.000 description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 229920000249 biocompatible polymer Polymers 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000004633 polyglycolic acid Substances 0.000 description 5
- 239000004626 polylactic acid Substances 0.000 description 5
- 238000007711 solidification Methods 0.000 description 5
- 230000008023 solidification Effects 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 229920002988 biodegradable polymer Polymers 0.000 description 4
- 239000004621 biodegradable polymer Substances 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- WHQSYGRFZMUQGQ-UHFFFAOYSA-N n,n-dimethylformamide;hydrate Chemical compound O.CN(C)C=O WHQSYGRFZMUQGQ-UHFFFAOYSA-N 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-Difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 240000002900 Arthrospira platensis Species 0.000 description 2
- 235000016425 Arthrospira platensis Nutrition 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000588879 Chromobacterium violaceum Species 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000122973 Stenotrophomonas maltophilia Species 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 229960000074 biopharmaceutical Drugs 0.000 description 2
- 229910052793 cadmium Inorganic materials 0.000 description 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 230000000779 depleting effect Effects 0.000 description 2
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Chemical compound CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 210000001822 immobilized cell Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 229920001308 poly(aminoacid) Polymers 0.000 description 2
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920001692 polycarbonate urethane Polymers 0.000 description 2
- 239000000622 polydioxanone Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- 229940082787 spirulina Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229920001897 terpolymer Polymers 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- ZYDBICLIXOCJJB-UHFFFAOYSA-N 2-chloro-1,3,4,4,5,6,6,7,8,8,8-undecafluoro-7-(trifluoromethyl)oct-1-ene Chemical compound FC(C(C(F)(F)F)(C(C(C(C(C(=CF)Cl)F)(F)F)F)(F)F)F)(F)F ZYDBICLIXOCJJB-UHFFFAOYSA-N 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 102100033167 Elastin Human genes 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229920002201 Oxidized cellulose Polymers 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002318 adhesion promoter Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229920003232 aliphatic polyester Polymers 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- MXWJVTOOROXGIU-UHFFFAOYSA-N atrazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)C)=N1 MXWJVTOOROXGIU-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000005686 electrostatic field Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 229940107304 oxidized cellulose Drugs 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920002627 poly(phosphazenes) Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001299 polypropylene fumarate Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 238000012514 protein characterization Methods 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0061—Electro-spinning characterised by the electro-spinning apparatus
- D01D5/0069—Electro-spinning characterised by the electro-spinning apparatus characterised by the spinning section, e.g. capillary tube, protrusion or pin
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/24—Formation of filaments, threads, or the like with a hollow structure; Spinnerette packs therefor
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/28—Formation of filaments, threads, or the like while mixing different spinning solutions or melts during the spinning operation; Spinnerette packs therefor
- D01D5/30—Conjugate filaments; Spinnerette packs therefor
- D01D5/34—Core-skin structure; Spinnerette packs therefor
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/04—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers
- D01F8/10—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers with at least one other macromolecular compound obtained by reactions only involving carbon-to-carbon unsaturated bonds as constituent
Definitions
- the present invention is directed to, inter alia, multi-layered electrospun microfibers and/or microtubes, comprising cells and/or molecules of interest.
- the invention is further directed to 5 compositions comprising said microfibers and/or microtubes and methods of use thereof in various applications.
- International application publication No. WO 2009/104174 provides a method of attaching a cell or a membrane-coated particle-of-interest to a microtube.
- International application publication No. WO 2009/104176 provides a method of attaching a cell or a molecule-of-interest 20 to a microtube.
- the present invention provides an electrospun concentric multi-layered microfiber comprising an exterior layer, an interior layer, and an intermediate layer residing between the exterior layer and the interior layer, said intermediate layer comprises one or more water soluble polymers, and said interior layer comprises one or more types of living cells and/or molecules of interest, and optionally one or more water soluble polymers and/or oligomers.
- a concentric multi-layered electrospun microfiber comprising an exterior layer, an interior layer, and an intermediate layer residing between the exterior layer and the interior layer, said intermediate layer comprises one or more water soluble polymers, and said interior layer comprises cells and/or molecules of interest.
- a concentric multi-layered electrospun 5 microfiber of the present invention wherein interior layer further comprises water soluble polymers or oligomers.
- said microfiber is hollow.
- said interior layer, intermediate layer and/or interior 10 layer are substantially porous layers.
- said water soluble polymers of said intermediate layer are selected from natural polymers, synthetic polymers or combinations thereof.
- said exterior layer comprises one or more organic soluble polymers.
- said organic soluble polymer of said exterior 15 layer is selected from the group consisting of: poly(vinylidenefluoride), poly (e-caprolactone) (PCL), polyamide, poly(siloxane), poly(silicone), poly(ethylene), poly(2-hydroxy ethylmethacrylate), poly(methyl methacrylate), poly(vinyl acetate), polyacrylamide, poly(ethylene-co-vinyl acetate), poly(methacrylic acid), polylactide, polyglycolide, poly(lactide-co-glycolide), polyanhydride, polyorthoester, poly(carbonate), poly(acrylo nitrile), polyaniline, polyvinyl carbazole, polystyrene, poly(vinyl phenol), polyhydroxyacid, poly(caprolactone), polyanhydride, polyhydroxyalkanoate, polyurethane, collagen, cellulose,
- said organic-soluble polymer is poly(vinylidenefluoride-co-hexafluor-opropylene) (PVDF-HFP).
- said exterior layer comprises water-soluble polymers.
- said exterior layer comprises water soluble polymers selected from the group consisting of: poly(vinyl pyrrolidone), poly(N-vinyl pyrrolidone), poly(vinyl alcohol), poly(acrylic acid), poly(ethylene glycol), poly(ethylene oxide), albumin, alginate, chitosan, starch, hyaluronic acid, albumin, alginate, chitosan, starch, polypetides and combination/copolymers thereof.
- said exterior layer further comprises antifouling agents.
- said water soluble polymers of said intermediate layer are selected from the group consisting of poly(acrylic acid), poly(vinyl pyrrolidone), poly(N-vinyl pyrrolidone), poly(vinyl alcohol), poly(acrylic acid) poly(ethylene glycol), poly(methacrylic acid), poly(ethylene oxide), polyhydroxyacid, alginate, starch, chitosan, dextran, albumin, chitosan, hyaluronic acid, polyppertides and combination/copolymers thereof.
- said water soluble polymers and/or oligomers of said interior layer are selected from natural and synthetic polymers and/or oligomers, or combinations thereof.
- said water soluble synthetic polymer is selected from the group consisting of PVA, PVP, PEO, PAA, polystyrene sulfonate and combinations or copolymers thereof.
- said water soluble natural polymer is selected from the group consisting of polysaccharides (e.g. alginate), starch, hyaluronic acid, alginate, dextran, chitosan and combinations or copolymers thereof.
- said oligomer is selected from the group consisting of chitosan oligomeric derivatives, and saccharides oligomers.
- the cell concentration within said internal layer or core is at least 10 OD.
- said interior layer further comprises media for maintaining and/or supporting said cell viability and/or activity.
- said molecules of interest are selected from hormones, growth factors, enzymes, nutrients and shock resistance molecules.
- said exterior layer has a thickness of about 5 nm to 10 micrometer.
- said intermediate layer has a thickness of about 5 nm to 10 micrometer.
- said internal layer has a thickness of about 5 nm to 10 micrometer.
- said interior layer has a diameter of at most 50 micrometer.
- a method for producing a concentric triple-layered microfiber comprising providing a first polymeric solution for forming an exterior layer of the microfiber, a second polymeric solution for forming an intermediate layer of the microfiber, and a third solution for forming an interior layer or a core of the microfiber, said third solution comprises cells; and co-electrospinning the first polymeric solution, second polymeric solution and the third solution through a triple-axial capillaries, thereby producing the concentric triple-layered microfiber.
- the first polymeric solution solidifies faster than the second polymeric solution.
- the second polymeric solution solidifies faster than the third solution.
- the second polymeric solution and said third solution comprise the same solvent.
- the second polymeric solution comprises a solvent which is incapable of dissolving the first polymeric solution.
- FIG. 1 illustrates a spinneret with three co-axial capillaries.
- FIGS. 2A-C illustrate triple-layered microfibers and/or microtubes according to some embodiments of the invention.
- the present invention provides, in one embodiment, concentric multi-layered electrospun microfibers or microtubes comprising cells and/or any biological elements.
- the invention further provides, in another embodiment, compositions, kits and systems comprising said microfibers and methods of use thereof In another embodiment, there is provided a method of fabricating said microfibers.
- the present invention is based, in part, on the surprising finding that a concentric multi-layered electrospun microfiber enables the incorporation of extremely high concentration of viable cells in the microfiber's internal layer or core.
- the microfibers disclosed herein were shown to incorporate viable cells at an extremely high concentration of about 50 OD (equivalent to about 10 11 cells/ml).
- the electrospun microfibers of the invention comprise an intermediate layer which acts as a barrier between the exterior layer (which comprises, in some embodiment, solvent harmful to cell or other biologics) and the interior layer comprising said cells.
- the incorporation of an intermediate layer between the exterior layer and the interior layer advantageously allows incorporation of high concentration of viable cells and/or biologics.
- the solvent selected for forming the exterior layer of the microfiber is an organic-based solvent and the solvent selected for forming the intermediate and/or internal layer of the microfiber is a solvent compatible for cell growth and viability.
- the present invention provides a multi-layered concentric electrospun microfiber or microtube comprising: (i) an exterior layer comprising one or more polymers, (ii) an interior layer or a core, and (iii) an intermediate (i.e., middle) layer situated between the exterior layer and the interior layer, said middle layer comprises one or more water-soluble polymers.
- the interior layer comprises a cell suspension, and/or a suspension of molecules of interest.
- the interior layer comprises one or more water soluble polymers and/or oligomers and cells and/or molecules of interest.
- the term “concentric” means that all layers of the multi-layer microfiber have a substantially common center, sharing a co-axial orientation. As such, concentric indicates that intermediate channels surround the core channel and, in turn, the outer channel surrounds the intermediate channels. In an embodiment, all the channels may share the same geometric center or axis.
- intermediate indicates that a layer is disposed between the core region and the outer layer.
- the outer layer will typically encompass the whole of the core region, at least in a cross section of the body, and the intermediate layer or layers will be disposed between the outer layer and the core region.
- the microfiber is a non-hollow fiber, comprising (or composed of) an external layer 20 (e.g., comprising organic-soluble polymers), an intermediate layer 20 optionally comprising water-soluble polymers, and an internal layer 40 encapsulating cells and/or molecules of interest 10 .
- Said internal layer 40 optionally comprises water-soluble polymers, as described herein.
- FIG. 2A illustrating a simplified, schematic illustration of a cross-section view of a portion of a triple-layer microfiber 200 , constructed and operative in accordance with another non-limiting embodiment of the present invention.
- non-hollow refers to an internal layer substantially filling the inner diameter of the fiber (i.e., the microfiber's core).
- said microfiber is at least a triple-layered microfiber.
- said microfiber is a triple-layered microfiber.
- said microfibers are substantially hollow, e.g., forming microtubes.
- a multi-layered concentric electrospun microtube refers to a hollow tube having an inner diameter of e.g., at most 50 ⁇ m, which is devoid of an electrospun polymer.
- said microtube is at least a triple-layered microtube.
- said multi-layer microtube comprises an external layer (e.g., comprising organic-soluble polymers), an intermediate layer comprising water-soluble polymers, and an internal layer comprising water-soluble polymers and encapsulated cells and/or molecules of interest.
- an external layer e.g., comprising organic-soluble polymers
- an intermediate layer comprising water-soluble polymers
- an internal layer comprising water-soluble polymers and encapsulated cells and/or molecules of interest.
- FIG. 2B illustrating a simplified, schematic illustration of a cross-section view of a portion of a multi-layer microfiber 300 , constructed and operative in accordance with another non-limiting embodiment of the present invention. It should be understood, that within such multi-layer microtube, cells may be entrapped in the internal layer of the microtube and/or in the internal lumen of the tube.
- said multi-layer microtube comprises an external layer (e.g., comprising organic-soluble polymers), an intermediate layer comprising water-soluble polymers, and an internal layer comprising cells and/or molecules of interest.
- an external layer e.g., comprising organic-soluble polymers
- an intermediate layer comprising water-soluble polymers
- an internal layer comprising cells and/or molecules of interest.
- the multi-layer microfiber 400 a double layered hollow microtube of the invention comprising an external layer 20 , and intermediate layer 30 and a third internal solution 40 comprising cells 10 and/or molecules of interest suspended in a liquid 10 (e.g., water, cell media, saline, etc.), filling the lumen of the tube without deposing of a layer.
- a liquid 10 e.g., water, cell media, saline, etc.
- said internal layer comprising cells is formed from an unspinnable solution.
- unspinnable solution refers to a solution which does not undergo stretching and elongation under an electrospinning process.
- the spinnability of a solution may be determined by one skilled in the art, such as by the viscoelasticity of the solution (e.g., according to the polymeric concentration and/or molecular weight within the solution).
- said intermediate layer is formed from an unspinnable solution so as to form a viscous layer (i.e., a layer which did not undergo stretching and elongation under a typical electrospinning process.
- the intermediate layer of the microfiber disclosed herein is substantially devoid of cells.
- An intermediate layer substantially devoid of cells refers to, in some embodiments, a layer being electrospun using a polymeric solution which is devoid of cells.
- the multi-layered microfiber and/or microtube of the invention are typically processed under a single-step process, i.e., a single electrospinning step.
- the multi-layered microfiber and/or microtube of the invention are processed by co-electrospinning three or more solutions through triple-axial or multi-axial capillaries, respectively. Methods of electrospinning the microfibers of the invention are further detailed herein below.
- said intermediate layer allows diffusion of the cells therethrough. In another embodiment, said intermediate layer substantially prevents diffusion of the cells therethrough.
- said intermediate layer is substantially porous and/or non-continuous.
- said porous layer comprises pores suitable for diffusion of nutrients and gasses (e.g., oxygen) to and from the encapsulated cells within the inner layer of said microfiber and/or microtube.
- said porous layer comprises pores of about 1 nm or more.
- said polymers of said intermediate layer are selected from natural polymers, synthetic polymers or combinations thereof.
- said intermediate layer comprises one or more water-soluble polymers.
- said intermediate layer is substantially devoid of cells.
- said polymers of said exterior layer are substantially biodegradable. In another embodiment, said polymers of said exterior layer are substantially not biodegradable.
- said exterior layer comprises one or more organic soluble polymers.
- organic-soluble polymers of said exterior layer include poly(vinylidenefluoride (PVDF), poly (e-caprolactone) (PCL), polyamide, poly(siloxane), poly(silicone), poly(ethylene), poly(2-hydroxy ethylmethacrylate), poly(methyl methacrylate), poly(vinyl acetate), polyacrylamide, poly(ethylene-co-vinyl acetate), poly(methacrylic acid), polylactide, polyglycolide, poly(lactide-coglycolide), polyanhydride, polyorthoester, poly(carbonate), poly(acrylo nitrile), polyaniline, polyvinyl carbazole, polystyrene, poly(vinyl phenol), polyhydroxyacid, poly(caprolactone), polyanhydride, polyhydroxyalkanoate, polyurethane, collagen, cellulose, and combination/copolymers thereof
- polymer selected from the group consisting of a polyvinylidene fluoride, a copolymer, or a terpolymer thereof containing a major portion of vinylidene fluoride.
- the polymer comprises polyvinylidene fluoride and at least one copolymerizable monomer selected from the group consisting of hexafluoropropylene, trifluoroethylene, chlorotrifluoroethylene, vinylfluoride and tetrafluoroethylene and any mixture of the homopolymer, copolymer, and terpolymer.
- said organic-soluble polymer is poly(vinylidenefluoride-co-hexafluor-opropylene) (PVDF-HFP).
- said exterior layer further comprises antifouling agents.
- said exterior layer comprises one or more water-soluble polymers.
- said interior layer comprises one or more water-soluble polymers.
- said intermediate layer comprises one or more water-soluble polymers.
- water soluble polymers include poly(acrylic acid), poly(vinyl pyrrolidone), poly(N-vinyl pyrrolidone), poly(vinyl alcohol), poly(acrylic acid) poly(ethylene glycol), poly(methacrylic acid), poly(ethylene oxide), polyhydroxyacid, alginate, starch, chitosan, dextran, albumin, hyaluronic acid, polypeptides and combination and/or copolymers thereof.
- water soluble polymers may be used to form the microtubes and/or microfibers of the invention.
- said water soluble polymers or oligomers of said interior layer are selected from natural polymers, synthetic polymers or combinations thereof.
- said water soluble synthetic polymer is selected from the group consisting of poly(vinyl alcohol) (PVA), Polyvinylpyrrolidone (PVP), poly(ethylene oxide) (PEO), and Poly(acrylic acid) (PAA).
- PVA poly(vinyl alcohol)
- PVP Polyvinylpyrrolidone
- PEO poly(ethylene oxide)
- PAA Poly(acrylic acid)
- said water soluble natural polymer is selected from the group consisting of polysaccharides (e.g. alginate, dextran, starch, hyaluronic acid), proteins (e.g. albumin).
- polysaccharides e.g. alginate, dextran, starch, hyaluronic acid
- proteins e.g. albumin
- said oligomers are selected from the group consisting of chitosan oligomeric derivatives.
- said internal layer comprises cell suspension and/or membrane-coated particles (e.g. liposomes) and/or biological elements including, but not limited to, enzymes, hormones, growth factor, salts, nutrients, preserving molecules, media and/or nutrients for maintaining and/or supporting said cell viability.
- cell suspension and/or membrane-coated particles e.g. liposomes
- biological elements including, but not limited to, enzymes, hormones, growth factor, salts, nutrients, preserving molecules, media and/or nutrients for maintaining and/or supporting said cell viability.
- said interior layer and/or said intermediate layer further comprises one or more agents selected from nutrients, shock resistance molecules (e.g. glycerol, trehalose, P, N, salts).
- shock resistance molecules e.g. glycerol, trehalose, P, N, salts.
- said exterior layer has a thickness of about 5 nm to one or more (e.g., 10) micrometers.
- said intermediate layer has a thickness of about 5 nm to 10 micron.
- said interior layer has a thickness of about 5 nm to 50 micrometer.
- said interior layer has a diameter of at most 50 micrometer.
- the term “cell” refers to a eukaryotic or prokaryotic cell.
- the cell comprises a cell wall.
- Non-limiting examples of cells which comprise a cell wall and which can be attached to the microfiber of the invention include plant cells, bacteria (e.g., Gram positive and Gram negative bacteria), archaea, protozoa, fungi (yeast), and algae.
- said cell is an animal cell such as human cells.
- said second solution comprises cells at a concentration of at least 15 Optical Density, at least 20 Optical Density, at least 25 Optical Density, at least 30 Optical Density, at least 35 Optical Density, at least 40 Optical Density, at least 45 Optical Density or at least 50 Optical Density.
- said third solution comprises cells at a concentration of at least of at least 3*10 ⁇ 10 cells/ml.
- the cell and/or the molecule of interest is a membrane-coated particle-of-interest such as a liposome or micelles.
- the cell comprises a dermis (e.g., insect cells).
- a dermis e.g., insect cells
- the cell has a diameter from about 500 nanometers to about 50 microns, e.g., from about 1-10 microns.
- cells include Chromobacterium violaceum, Pseudomonas maltophila, Pseudomonas aeruginosa, Spirulina planensis, Staphylococcus aureus, Bacillus cereus, Bacillus subtilis and Escherichia coli.
- the cells may be attached to the polymer(s) comprised in the microfiber via covalent or non-covalent binding (e.g., via an electrostatic bond, a hydrogen bond, a van-Der Waals interaction) so as to obtain an absorbed, embedded or immobilized cell to the inner layer of the microfiber of the invention.
- covalent or non-covalent binding e.g., via an electrostatic bond, a hydrogen bond, a van-Der Waals interaction
- covalent attachment of the cell can be via functional groups such as SH groups, amino groups, carboxyl groups which are added to the polymer(s) forming the microfiber.
- the cells adhere to the inner layer of the microfiber by use of cell adhesion promoters such as fibronectin.
- microfibers and microtubes or compositions comprising same are used in various applications including but not limited to water purification, detoxification, bio-chemicals fermentations, mineral enrichment, tissue grafts and cell-based therapy.
- a method of bioremediation comprising contacting a solution containing a contaminant with the microfiber or microtube of some embodiments of the invention, wherein the cell, a portion of the cell or is capable of degrading or assimilating the contaminant.
- a method of depleting a molecule from a solution comprising contacting the solution with the microfiber or microtube of some embodiments of the invention, wherein the molecule is capable of binding to or being processed by the cell, thereby depleting the molecule from the solution.
- a method of isolating a molecule from a solution comprising: (a) contacting the solution with the microfiber or microtube of some embodiments of the invention under conditions which allow binding of the molecule to the cell, and; (b) eluting the molecule from the microfiber or the microtube; thereby isolating the molecule from the solution.
- a method of detecting a presence of a molecule in a sample comprising: (a) contacting the sample with the microfiber or microtube of some embodiments of the invention, wherein the cell is capable of binding to or processing the molecule, and; (b) detecting the binding or the processing; thereby detecting the presence of the molecule in the sample.
- Water purification usually entails the removal of toxic chemicals such as mercury, mercurial compounds, and cadmium or elements such as toluene, chloroform, benzene, pesticides and herbicides.
- said cell is Pseudomonads.
- said Pseudomonads is used to degrade toluene, benzene, phenol, naphthalene, atrazine, and/or certain hydrocarbons from oil.
- the microfibers or compositions comprising same are used in water systems for removal of toxic heavy metals such as cadmium and mercury.
- toxic heavy metals such as cadmium and mercury.
- bacterial strains useful for such application include Chromobacterium violaceum, Pseudomonas maltophila, Pseudomonas aeruginosa, Spirulina planensis, Staphylococcus aureus, Bacillus cereus, Bacillus subtilis and Escherichia coli.
- each layer of said microfiber or microtube provides a separate phase of sustained release.
- microfibers or compositions comprising same are used in fermentation methods.
- a method for producing the microfibers or microtubes of the invention comprising co-electrospinning three solutions through triple-axial capillaries.
- FIG. 1 illustrating a triple-axial capillary (e.g., a spinneret with three co-axial capillaries) used for the triple axial co-electrospining procedure for forming a concentric triple-layer electrospun microfiber or microtube of the invention.
- a triple-axial capillary e.g., a spinneret with three co-axial capillaries
- a method for producing a concentric triple-layered microfiber comprising providing a first polymeric solution for forming an exterior layer of the microfiber, a second polymeric solution for forming an intermediate layer of the microfiber, and a third solution for forming an interior layer or a core of the microfiber, said third solution comprises cells; and co-electrospinning the first polymeric solution, second polymeric solution and the third solution through a triple-axial capillaries, thereby producing the concentric triple-layered microfiber.
- the multi-layered microfiber or microtube comprises an exterior layer formed of a first polymeric solution, an intermediate layer formed of a second polymeric solution, and/or an interior layer formed of a third solution (a polymeric solution or a solution devoid of polymers).
- said first polymeric solution solidifies faster than said second polymeric solution. In another embodiment, said second polymeric solution solidifies faster than said third polymeric solution.
- the solvent selected for forming the exterior layer of the microfiber is an organic-based solvent and the solvent selected for forming the intermediate and/or internal layer of the microfiber is a solvent compatible for cell growth and viability.
- an “organic solvent” relate to a chemical class of compounds that are used routinely in commercial industries, which typically share a common structure (at least 1 carbon atom and 1 hydrogen atom), low molecular weight, lipophilicity, and volatility, and they exist in liquid form at room temperature.
- the organic solvents are aliphatic-chain compounds, such as n-hexane.
- the organic solvents are aromatic compounds with a 6-carbon ring, such as benzene or xylene.
- Aliphatics and aromatics may contain a substituted halogen element and may be referred to as halogenated hydrocarbons, such as perchloroethylene (PCE or PER), trichloroethylene (TCE), and carbon tetrachloride.
- PCE or PER perchloroethylene
- TCE trichloroethylene
- COC carbon tetrachloride
- Alcohols, ketones, glycols, esters, ethers, aldehydes, and pyridines are substitutions for a hydrogen group.
- a “solvent compatible for cell growth and viability” relates to a solvent which is substantially not-toxic for a cell.
- solvents include water, glycerol-based solutions, and cell culture media.
- a solvent of said second polymeric solution is incapable of dissolving said first polymeric solution.
- a solvent of said third polymeric solution is incapable of dissolving said second polymeric solution.
- the second polymeric solution and said third solution comprise the same solvent.
- co-electrospinning refers to a process in which at least three solutions (out of which at least two are polymeric solutions) are electrospun from co-axial capillaries (i.e., at least three capillary dispensers wherein one capillary is placed within an intermediate capillary which is placed within a third capillary while sharing a co-axial orientation) forming the spinneret.
- the capillary can be, for example, a syringe with a metal needle or a bath provided with one or more capillary apertures from which the polymeric solutions can be extruded, e.g., under the action of hydrostatic pressure, mechanical pressure, air pressure and/or high voltage.
- the collector serves for collecting the electrospun element (e.g., the electrospun microfiber) thereupon.
- a collector can be a rotating collector or a static (non-rotating) collector.
- a rotating collector When a rotating collector is used, such a collector may have a cylindrical shape (e.g., a drum), however, the rotating collector can be also of a planar geometry (e.g., an horizontal disk).
- the spinneret is typically connected to a source of high voltage, such as of positive polarity, while the collector is grounded, thus forming an electrostatic field between the dispensing capillary (dispenser) and the collector.
- the spinneret can be grounded while the collector is connected to a source of high voltage, such as with negative polarity.
- any of the above configurations establishes motion of a positively charged jet from the spinneret to the collector.
- Reverse polarity for establishing motions of a negatively charged jet from the spinneret to the collector are also contemplated.
- the first polymeric solution is injected into the outer capillary of the co-axial capillaries, the second polymeric solution is injected into the intermediate capillary of the co-axial capillaries, while the third solution is injected into the inner capillary of the co-axial capillaries.
- the first polymeric solution which is for forming the exterior layer of the microfiber
- the second polymeric solution solidifies faster than the second polymeric solution (for forming the middle/intermediate layer of the microfiber), which in turn, solidifies faster than the third polymeric solution (for forming the interior layer of the microfiber).
- the third polymeric solution (for forming the interior layer) is not a polymeric solution.
- the interior layer is formed by electrospinning a suspension of cells and/or molecules of interest.
- the formation of a microfiber also requires that the solvent of the second polymeric solution be incapable of dissolving the first polymeric solution.
- the solvent of the third polymeric solution is similar or identical to the solvent of the second polymeric solution In another embodiment, the solvent of the third polymeric solution be incapable of dissolving the second polymeric solution.
- the solidification rates of the first, second and third polymeric solutions may be critical for forming the microfiber.
- the solidification of the first polymer (of the first polymeric solution) can be within about 30 milliseconds (ms)
- the solidification of the second polymer (of the second polymeric solution) can be within about 10-20 seconds
- the solidification of the third polymer (of the third polymeric solution) can be substantially longer than the second polymer.
- the solidification may be a result of polymerization rate and/or evaporation rate.
- polymeric solution refers to a soluble polymer, i.e., a liquid medium containing one or more polymers, co-polymers or blends of polymers dissolved in a solvent or mixture of solvents.
- the polymer used by the invention can be a natural, synthetic, biocompatible and/or biodegradable polymer. 15
- synthetic polymer refers to polymers that are not found in nature, even if the polymers are made from naturally occurring biomaterials. Examples include, but are not limited to, aliphatic polyesters, poly(amino acids), copoly(ether-esters), polyalkylenes, oxalates, polyamides, tyrosine derived polycarbonates, poly(iminocarbonates), polyorthoesters, polyoxaesters, polyamidoesters, polyoxaesters containing amine groups, poly(anhydrides), polyphosphazenes, and combinations thereof.
- Suitable synthetic polymers for use by the invention can also include biosynthetic polymers based on sequences found in naturally occurring proteins such as those of collagen, elastin, thrombin, fibronectin, or mutant or synthetic derivatives thereof or, starches, poly(amino acids), poly(propylene fumarate), gelatin, alginate, pectin, fibrin, oxidized cellulose, chitin, chitosan, tropoelastin, hyaluronic acid, polyethylene, polyethylene terephthalate, poly(tetrafluoroethylene), polycarbonate, polypropylene and poly(vinyl alcohol), ribonucleic acids, deoxyribonucleic acids, polypeptides, proteins, polysaccharides, polynucleotides and combinations thereof.
- biosynthetic polymers based on sequences found in naturally occurring proteins such as those of collagen, elastin, thrombin, fibronectin, or mutant or synthetic derivatives thereof or, starches
- natural polymer refers to polymers that are naturally occurring.
- Non-limiting examples of such polymers include, silk, collagen-based materials, chitosan, hyaluronic acid, albumin, fibrinogen, and alginate.
- co-polymer refers to a polymer of at least two chemically distinct monomers.
- co-polymers include, polylactic acid (PLA)-polyethyleneglycol (PEG), polyethylene glycol terephthalate (PEGT)/polybutylene terephthalate (PBT), PLA-polyglycolic acid (PGA), PEG-polycaprolactone (PCL) and PCL-PLA.
- blends of polymers refers to the result of mixing two or more polymers together to create a new solution/composition with different physical properties.
- biocompatible polymer refers to any polymer (synthetic or natural) which when in contact with cells, tissues or body fluid of an organism does not induce adverse effects such as immunological reactions and/or rejections, cellular death, and the like.
- a biocompatible polymer can also be a biodegradable polymer.
- the first, the second and/or the third polymeric solutions are biocompatible.
- biocompatible polymers include polyesters (PE), PCL, PLA, PGA, PEG, polyvinyl alcohol, polyvinyl pyrrolidone, polytetrafluoroethylene (PTFE, teflon), polypropylene (PP), polyvinylchloride (PVC), polymethylmethacrylate (PMMA), polyamides, segmented polyurethane, polycarbonate-urethane and thermoplastic polyether urethane, silicone-polyether-urethane, silicone-polycarbonate-urethane collagen, PEG-DMA, alginate, hydroxyapatite and chitosan, blends and copolymers thereof.
- biodegradable polymer refers to a synthetic or natural polymer which can be degraded (i.e., broken down) in a physiological environment such as by proteases or other enzymes produced by living organisms such as bacteria, fungi, plants and animals. Biodegradability depends on the availability of degradation substrates (i.e., biological materials or portion thereof which are part of the polymer), the presence of biodegrading materials (e.g., microorganisms, enzymes, proteins) and the availability of oxygen (for aerobic organisms, microorganisms or portions thereof), lack of oxygen (for anaerobic organisms, microorganisms or portions thereof) and/or other nutrients.
- degradation substrates i.e., biological materials or portion thereof which are part of the polymer
- biodegrading materials e.g., microorganisms, enzymes, proteins
- oxygen for aerobic organisms, microorganisms or portions thereof
- lack of oxygen for anaerobic organisms, microorganisms or portions thereof
- biodegradable polymers/materials include, but are not limited to, collagen (e.g., collagen I or IV), fibrin, hyaluronic acid, polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyethyleneglycol (PEG), collagen, PEG-DMA, alginate, chitosan copolymers or mixtures thereof.
- collagen e.g., collagen I or IV
- fibrin hyaluronic acid
- PLA polylactic acid
- PGA polyglycolic acid
- PCL polycaprolactone
- PDO polydioxanone
- TMC trimethylene carbonate
- PEG polyethyleneglycol
- collagen PEG-DMA
- alginate chitosan copolymers or mixtures thereof.
- the polymeric solution can be made of one or more polymers, each can be a polymer or a co-polymer such as described hereinabove.
- the polymeric solution is a mixture of at least one biocompatible polymer and a co-polymer (either biodegradable or non-biodegradable).
- one or more layers of the microfiber may comprise pores, thus creating a “breathing” tube.
- Methods of forming “breathing” microtube i.e., microtubes with pores in the shell thereof) are described in PCT/IB2007/054001 to Zussman E., et al., which is fully incorporated herein by reference.
- “breathing” fibers and/or tubes can be formed by the inclusion of a high percent (e.g., at least 80%) of a volatile component such as tetrahydrofuran (THF), chloroform, acetone, or trifluoroefhanol (TFE) in the first polymeric solution, and/or by the inclusion of a water-soluble polymer such as polyethylene glycol (PEG) in the first polymeric solution so that the first polymeric solution comprises a blend of polymers in which one is water-soluble and the other is water-insoluble (e.g., a blend of PEG and PCL).
- a volatile component such as tetrahydrofuran (THF), chloroform, acetone, or trifluoroefhanol (TFE)
- TFE trifluoroefhanol
- PEG polyethylene glycol
- “breathing” microtubes can be formed by inducing pores in one or more layers of the microfiber, after the completion of the electrospinning process, essentially as described in PCT WO 2006/106506, which is fully incorporated herein by reference, such as by passing an electrical spark or a heated puncturing element through the electrospun microfiber, or by using a pulsed or continuous laser beam through the electrospun microfiber.
- the first polymeric solution comprises PEG for inducing pores in the exterior layer of the microfiber.
- the first polymeric solution may include about 4% PEG MW 35 kDa.
- the first polymeric solution may include about 2% PEG MW 6 kDa or less.
- the microfiber can be designed for selective passage of certain molecules or particles.
- the passage through the exterior layer pores depends on the size and/or the electrical charge of the molecules/particles with respect to the geometry (length and radius), surface energy, electrical charge of the shell pores, and the viscosity and surface tension of the liquid containing the molecules/particles.
- the porosity i.e., the ratio of the volume of the pores to the volume of the mass
- pore size can control the release of the cell/molecules 30 from the microfiber.
- a layer with pores larger than 1 ⁇ m in diameter e.g., about 1-2 ⁇ m
- increased porosity can result in a greater rate of release through the pores.
- the microfiber can be made such that it prevents diffusion or passage of the cell, or any molecule therethrough (e.g., substantially devoid of pores, or with pores having a diameter which is smaller than the cell, or which exhibit a geometry which prevents passage of cells or membrane-coated particles therethrough).
- any molecule therethrough e.g., substantially devoid of pores, or with pores having a diameter which is smaller than the cell, or which exhibit a geometry which prevents passage of cells or membrane-coated particles therethrough).
- Table 1 represents different compositions used for fabricating the electrospun fibers using tri-axial spinnerets.
- Encapsulation of yeast in fibers was successfully achieved using all compositions and spinning parameters given in the table above.
- the encapsulated yeast remained alive, active and proliferated inside the fibers utilizing the internal space of the fiber/tube and expand until full space was occupied with a densely packed cells.
Abstract
Description
- The present invention is directed to, inter alia, multi-layered electrospun microfibers and/or microtubes, comprising cells and/or molecules of interest. The invention is further directed to 5 compositions comprising said microfibers and/or microtubes and methods of use thereof in various applications.
- International application publication No. WO 2008/041183 provides
electrospun 10 microtubes and a method of producing a microtube, comprising co-electrospinning two polymeric solutions through co-axial capillaries to thereby produce the microtube, wherein a first polymeric solution of the two polymeric solutions is for forming a shell of the microtube and a second polymeric solution of the two polymeric solutions is for forming a coat over an internal surface of the shell, the first polymeric solution is selected solidifying faster than the second polymeric 15 solution and a solvent of the second polymeric solution is selected incapable of dissolving the first polymeric solution. - International application publication No. WO 2009/104174 provides a method of attaching a cell or a membrane-coated particle-of-interest to a microtube. International application publication No. WO 2009/104176 provides a method of attaching a cell or a molecule-of-
interest 20 to a microtube. - There is a need for improved electrospun cell-bearing microtubes and/or microfibers with increased cell viability and density.
- SUMMARY OF THE INVENTION
- According to one aspect, the present invention provides an electrospun concentric multi-layered microfiber comprising an exterior layer, an interior layer, and an intermediate layer residing between the exterior layer and the interior layer, said intermediate layer comprises one or more water soluble polymers, and said interior layer comprises one or more types of living cells and/or molecules of interest, and optionally one or more water soluble polymers and/or oligomers. 30
- According to another embodiment, there is provided a concentric multi-layered electrospun microfiber comprising an exterior layer, an interior layer, and an intermediate layer residing between the exterior layer and the interior layer, said intermediate layer comprises one or more water soluble polymers, and said interior layer comprises cells and/or molecules of interest.
- According to another embodiment, there is provided a concentric multi-layered electrospun 5 microfiber of the present invention, wherein interior layer further comprises water soluble polymers or oligomers.
- According to another embodiment, there is provided a triple-layer microfiber.
- According to another embodiment, said microfiber is hollow.
- According to another embodiment, said interior layer, intermediate layer and/or interior 10 layer are substantially porous layers.
- According to another embodiment, said water soluble polymers of said intermediate layer are selected from natural polymers, synthetic polymers or combinations thereof.
- According to another embodiment, said exterior layer comprises one or more organic soluble polymers. According to another embodiment, said organic soluble polymer of said exterior 15 layer is selected from the group consisting of: poly(vinylidenefluoride), poly (e-caprolactone) (PCL), polyamide, poly(siloxane), poly(silicone), poly(ethylene), poly(2-hydroxy ethylmethacrylate), poly(methyl methacrylate), poly(vinyl acetate), polyacrylamide, poly(ethylene-co-vinyl acetate), poly(methacrylic acid), polylactide, polyglycolide, poly(lactide-co-glycolide), polyanhydride, polyorthoester, poly(carbonate), poly(acrylo nitrile), polyaniline, polyvinyl carbazole, polystyrene, poly(vinyl phenol), polyhydroxyacid, poly(caprolactone), polyanhydride, polyhydroxyalkanoate, polyurethane, collagen, cellulose, and combination/copolymers thereof.
- According to another embodiment, said organic-soluble polymer is poly(vinylidenefluoride-co-hexafluor-opropylene) (PVDF-HFP).
- According to another embodiment, said exterior layer comprises water-soluble polymers. 25 According to another embodiment, said exterior layer comprises water soluble polymers selected from the group consisting of: poly(vinyl pyrrolidone), poly(N-vinyl pyrrolidone), poly(vinyl alcohol), poly(acrylic acid), poly(ethylene glycol), poly(ethylene oxide), albumin, alginate, chitosan, starch, hyaluronic acid, albumin, alginate, chitosan, starch, polypetides and combination/copolymers thereof.
- According to another embodiment, said exterior layer further comprises antifouling agents.
- According to another embodiment, said water soluble polymers of said intermediate layer are selected from the group consisting of poly(acrylic acid), poly(vinyl pyrrolidone), poly(N-vinyl pyrrolidone), poly(vinyl alcohol), poly(acrylic acid) poly(ethylene glycol), poly(methacrylic acid), poly(ethylene oxide), polyhydroxyacid, alginate, starch, chitosan, dextran, albumin, chitosan, hyaluronic acid, polyppertides and combination/copolymers thereof.
- According to another embodiment, said water soluble polymers and/or oligomers of said interior layer are selected from natural and synthetic polymers and/or oligomers, or combinations thereof.
- According to another embodiment, said water soluble synthetic polymer is selected from the group consisting of PVA, PVP, PEO, PAA, polystyrene sulfonate and combinations or copolymers thereof.
- According to another embodiment, said water soluble natural polymer is selected from the group consisting of polysaccharides (e.g. alginate), starch, hyaluronic acid, alginate, dextran, chitosan and combinations or copolymers thereof.
- According to another embodiment, said oligomer is selected from the group consisting of chitosan oligomeric derivatives, and saccharides oligomers.
- According to another embodiment, the cell concentration within said internal layer or core is at least 10 OD.
- According to another embodiment, said interior layer further comprises media for maintaining and/or supporting said cell viability and/or activity.
- According to another embodiment, said molecules of interest are selected from hormones, growth factors, enzymes, nutrients and shock resistance molecules.
- According to another embodiment, said exterior layer has a thickness of about 5 nm to 10 micrometer.
- According to another embodiment, said intermediate layer has a thickness of about 5 nm to 10 micrometer.
- According to another embodiment, said internal layer has a thickness of about 5 nm to 10 micrometer.
- According to another embodiment, said interior layer has a diameter of at most 50 micrometer.
- According to another aspect, there is provided a method for producing a concentric triple-layered microfiber, the method comprising providing a first polymeric solution for forming an exterior layer of the microfiber, a second polymeric solution for forming an intermediate layer of the microfiber, and a third solution for forming an interior layer or a core of the microfiber, said third solution comprises cells; and co-electrospinning the first polymeric solution, second polymeric solution and the third solution through a triple-axial capillaries, thereby producing the concentric triple-layered microfiber.
- According to another embodiment, the first polymeric solution solidifies faster than the second polymeric solution.
- According to another embodiment, the second polymeric solution solidifies faster than the third solution.
- According to another embodiment, the second polymeric solution and said third solution comprise the same solvent.
- According to another embodiment, the second polymeric solution comprises a solvent which is incapable of dissolving the first polymeric solution.
- Further embodiments and the full scope of applicability of the present invention will become apparent from the detailed description given hereinafter. However, it should be understood that the detailed description and specific examples, while indicating preferred embodiments of the invention, are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from this detailed description.
-
FIG. 1 illustrates a spinneret with three co-axial capillaries. -
FIGS. 2A-C illustrate triple-layered microfibers and/or microtubes according to some embodiments of the invention. - The present invention provides, in one embodiment, concentric multi-layered electrospun microfibers or microtubes comprising cells and/or any biological elements. The invention further provides, in another embodiment, compositions, kits and systems comprising said microfibers and methods of use thereof In another embodiment, there is provided a method of fabricating said microfibers.
- The present invention is based, in part, on the surprising finding that a concentric multi-layered electrospun microfiber enables the incorporation of extremely high concentration of viable cells in the microfiber's internal layer or core. In an exemplary embodiment, the microfibers disclosed herein were shown to incorporate viable cells at an extremely high concentration of about 50 OD (equivalent to about 1011 cells/ml).
- The electrospun microfibers of the invention comprise an intermediate layer which acts as a barrier between the exterior layer (which comprises, in some embodiment, solvent harmful to cell or other biologics) and the interior layer comprising said cells. The incorporation of an intermediate layer between the exterior layer and the interior layer advantageously allows incorporation of high concentration of viable cells and/or biologics. In some embodiments, the solvent selected for forming the exterior layer of the microfiber is an organic-based solvent and the solvent selected for forming the intermediate and/or internal layer of the microfiber is a solvent compatible for cell growth and viability.
- According to another embodiment, the present invention provides a multi-layered concentric electrospun microfiber or microtube comprising: (i) an exterior layer comprising one or more polymers, (ii) an interior layer or a core, and (iii) an intermediate (i.e., middle) layer situated between the exterior layer and the interior layer, said middle layer comprises one or more water-soluble polymers. In one embodiment, the interior layer comprises a cell suspension, and/or a suspension of molecules of interest. In another embodiment, the interior layer comprises one or more water soluble polymers and/or oligomers and cells and/or molecules of interest.
- As used herein, the term “concentric” means that all layers of the multi-layer microfiber have a substantially common center, sharing a co-axial orientation. As such, concentric indicates that intermediate channels surround the core channel and, in turn, the outer channel surrounds the intermediate channels. In an embodiment, all the channels may share the same geometric center or axis.
- As used herein, “intermediate” indicates that a layer is disposed between the core region and the outer layer. The outer layer will typically encompass the whole of the core region, at least in a cross section of the body, and the intermediate layer or layers will be disposed between the outer layer and the core region.
- Reference is now made to
FIGS. 2A, 2B, and 2C , illustrating a simplified, schematic illustration of a cross-section view of a portion of a multi-layer microfiber of the invention. In another embodiment, the microfiber is a non-hollow fiber, comprising (or composed of) an external layer 20 (e.g., comprising organic-soluble polymers), anintermediate layer 20 optionally comprising water-soluble polymers, and aninternal layer 40 encapsulating cells and/or molecules ofinterest 10. Saidinternal layer 40 optionally comprises water-soluble polymers, as described herein. - Reference is made to
FIG. 2A , illustrating a simplified, schematic illustration of a cross-section view of a portion of a triple-layer microfiber 200, constructed and operative in accordance with another non-limiting embodiment of the present invention. - The term “non-hollow”, as used herein, refers to an internal layer substantially filling the inner diameter of the fiber (i.e., the microfiber's core). In another embodiment, said microfiber is at least a triple-layered microfiber. In another embodiment, said microfiber is a triple-layered microfiber.
- In some embodiment, said microfibers are substantially hollow, e.g., forming microtubes. In one embodiment, there is provided a multi-layered concentric electrospun microtube. As used herein, the term “microtube” refers to a hollow tube having an inner diameter of e.g., at most 50 μm, which is devoid of an electrospun polymer. In another embodiment, said microtube is at least a triple-layered microtube.
- In one embodiment, said multi-layer microtube comprises an external layer (e.g., comprising organic-soluble polymers), an intermediate layer comprising water-soluble polymers, and an internal layer comprising water-soluble polymers and encapsulated cells and/or molecules of interest. Reference is made to
FIG. 2B , illustrating a simplified, schematic illustration of a cross-section view of a portion of amulti-layer microfiber 300, constructed and operative in accordance with another non-limiting embodiment of the present invention. It should be understood, that within such multi-layer microtube, cells may be entrapped in the internal layer of the microtube and/or in the internal lumen of the tube. - In one embodiment, said multi-layer microtube comprises an external layer (e.g., comprising organic-soluble polymers), an intermediate layer comprising water-soluble polymers, and an internal layer comprising cells and/or molecules of interest. Reference is made to
FIG. 2C , illustrating a simplified, schematic illustration of a cross-section view of a portion of amulti-layer microfiber 400, constructed and operative in accordance with another non-limiting embodiment of the present invention. The multi-layer microfiber 400 a double layered hollow microtube of the invention comprising anexternal layer 20, andintermediate layer 30 and a thirdinternal solution 40 comprisingcells 10 and/or molecules of interest suspended in a liquid 10 (e.g., water, cell media, saline, etc.), filling the lumen of the tube without deposing of a layer. - According to one embodiment, said internal layer comprising cells is formed from an unspinnable solution. As used herein, the term “unspinnable solution” refers to a solution which does not undergo stretching and elongation under an electrospinning process. The spinnability of a solution may be determined by one skilled in the art, such as by the viscoelasticity of the solution (e.g., according to the polymeric concentration and/or molecular weight within the solution).
- According to some embodiments, said intermediate layer is formed from an unspinnable solution so as to form a viscous layer (i.e., a layer which did not undergo stretching and elongation under a typical electrospinning process. In another embodiment, the intermediate layer of the microfiber disclosed herein is substantially devoid of cells. An intermediate layer substantially devoid of cells refers to, in some embodiments, a layer being electrospun using a polymeric solution which is devoid of cells.
- The multi-layered microfiber and/or microtube of the invention are typically processed under a single-step process, i.e., a single electrospinning step. In another embodiment, the multi-layered microfiber and/or microtube of the invention are processed by co-electrospinning three or more solutions through triple-axial or multi-axial capillaries, respectively. Methods of electrospinning the microfibers of the invention are further detailed herein below.
- In one embodiment, said intermediate layer allows diffusion of the cells therethrough. In another embodiment, said intermediate layer substantially prevents diffusion of the cells therethrough.
- In another embodiment, said intermediate layer is substantially porous and/or non-continuous. In another embodiment, said porous layer comprises pores suitable for diffusion of nutrients and gasses (e.g., oxygen) to and from the encapsulated cells within the inner layer of said microfiber and/or microtube. In one embodiment, said porous layer comprises pores of about 1 nm or more.
- In another embodiment, said polymers of said intermediate layer are selected from natural polymers, synthetic polymers or combinations thereof. In another embodiment, said intermediate layer comprises one or more water-soluble polymers. In another embodiment, said intermediate layer is substantially devoid of cells.
- In one embodiment, said polymers of said exterior layer are substantially biodegradable. In another embodiment, said polymers of said exterior layer are substantially not biodegradable.
- In another embodiment, said exterior layer comprises one or more organic soluble polymers. None limiting examples of organic-soluble polymers of said exterior layer include poly(vinylidenefluoride (PVDF), poly (e-caprolactone) (PCL), polyamide, poly(siloxane), poly(silicone), poly(ethylene), poly(2-hydroxy ethylmethacrylate), poly(methyl methacrylate), poly(vinyl acetate), polyacrylamide, poly(ethylene-co-vinyl acetate), poly(methacrylic acid), polylactide, polyglycolide, poly(lactide-coglycolide), polyanhydride, polyorthoester, poly(carbonate), poly(acrylo nitrile), polyaniline, polyvinyl carbazole, polystyrene, poly(vinyl phenol), polyhydroxyacid, poly(caprolactone), polyanhydride, polyhydroxyalkanoate, polyurethane, collagen, cellulose, and combination/copolymers thereof. One skilled in the art will appreciate that other organic soluble polymers may be used to form the microtubes and/or microfibers of the invention.
- In some embodiments, there is provided polymer selected from the group consisting of a polyvinylidene fluoride, a copolymer, or a terpolymer thereof containing a major portion of vinylidene fluoride. In some embodiments, the polymer comprises polyvinylidene fluoride and at least one copolymerizable monomer selected from the group consisting of hexafluoropropylene, trifluoroethylene, chlorotrifluoroethylene, vinylfluoride and tetrafluoroethylene and any mixture of the homopolymer, copolymer, and terpolymer. In some embodiments, said organic-soluble polymer is poly(vinylidenefluoride-co-hexafluor-opropylene) (PVDF-HFP).
- In another embodiment, said exterior layer further comprises antifouling agents.
- In another embodiment, said exterior layer comprises one or more water-soluble polymers. In another embodiment, said interior layer comprises one or more water-soluble polymers. In another embodiment, said intermediate layer comprises one or more water-soluble polymers.
- None limiting examples of said water soluble polymers include poly(acrylic acid), poly(vinyl pyrrolidone), poly(N-vinyl pyrrolidone), poly(vinyl alcohol), poly(acrylic acid) poly(ethylene glycol), poly(methacrylic acid), poly(ethylene oxide), polyhydroxyacid, alginate, starch, chitosan, dextran, albumin, hyaluronic acid, polypeptides and combination and/or copolymers thereof. One skilled in the art will appreciate that other water soluble polymers may be used to form the microtubes and/or microfibers of the invention.
- In another embodiment, said water soluble polymers or oligomers of said interior layer are selected from natural polymers, synthetic polymers or combinations thereof.
- In another embodiment, said water soluble synthetic polymer is selected from the group consisting of poly(vinyl alcohol) (PVA), Polyvinylpyrrolidone (PVP), poly(ethylene oxide) (PEO), and Poly(acrylic acid) (PAA).
- In another embodiment, said water soluble natural polymer is selected from the group consisting of polysaccharides (e.g. alginate, dextran, starch, hyaluronic acid), proteins (e.g. albumin).
- In another embodiment, said oligomers are selected from the group consisting of chitosan oligomeric derivatives.
- In another embodiment, said internal layer comprises cell suspension and/or membrane-coated particles (e.g. liposomes) and/or biological elements including, but not limited to, enzymes, hormones, growth factor, salts, nutrients, preserving molecules, media and/or nutrients for maintaining and/or supporting said cell viability.
- In another embodiment, said interior layer and/or said intermediate layer further comprises one or more agents selected from nutrients, shock resistance molecules (e.g. glycerol, trehalose, P, N, salts).
- In another embodiment, said exterior layer has a thickness of about 5 nm to one or more (e.g., 10) micrometers. In another embodiment, said intermediate layer has a thickness of about 5 nm to 10 micron. In another embodiment, said interior layer has a thickness of about 5 nm to 50 micrometer. In another embodiment, said interior layer has a diameter of at most 50 micrometer.
- As used herein the term “cell” refers to a eukaryotic or prokaryotic cell. According to some embodiments of the invention, the cell comprises a cell wall. Non-limiting examples of cells which comprise a cell wall and which can be attached to the microfiber of the invention include plant cells, bacteria (e.g., Gram positive and Gram negative bacteria), archaea, protozoa, fungi (yeast), and algae. In another embodiment, said cell is an animal cell such as human cells.
- According some embodiments, said second solution comprises cells at a concentration of at least 15 Optical Density, at least 20 Optical Density, at least 25 Optical Density, at least 30 Optical Density, at least 35 Optical Density, at least 40 Optical Density, at least 45 Optical Density or at least 50 Optical Density. According some embodiments, said third solution comprises cells at a concentration of at least of at least 3*10̂10 cells/ml.
- According to some embodiments of the invention, the cell and/or the molecule of interest is a membrane-coated particle-of-interest such as a liposome or micelles.
- According to some embodiments of the invention, the cell comprises a dermis (e.g., insect cells).
- According to some embodiments of the invention, the cell has a diameter from about 500 nanometers to about 50 microns, e.g., from about 1-10 microns.
- None limiting examples of cells include Chromobacterium violaceum, Pseudomonas maltophila, Pseudomonas aeruginosa, Spirulina planensis, Staphylococcus aureus, Bacillus cereus, Bacillus subtilis and Escherichia coli.
- Typically, the cells may be attached to the polymer(s) comprised in the microfiber via covalent or non-covalent binding (e.g., via an electrostatic bond, a hydrogen bond, a van-Der Waals interaction) so as to obtain an absorbed, embedded or immobilized cell to the inner layer of the microfiber of the invention.
- According to some embodiments of the invention, covalent attachment of the cell can be via functional groups such as SH groups, amino groups, carboxyl groups which are added to the polymer(s) forming the microfiber.
- According to some embodiments of the invention, the cells adhere to the inner layer of the microfiber by use of cell adhesion promoters such as fibronectin.
- In one embodiment, the microfibers and microtubes or compositions comprising same are used in various applications including but not limited to water purification, detoxification, bio-chemicals fermentations, mineral enrichment, tissue grafts and cell-based therapy.
- According to an aspect of some embodiments of the present invention there is provided a method of bioremediation, the method comprising contacting a solution containing a contaminant with the microfiber or microtube of some embodiments of the invention, wherein the cell, a portion of the cell or is capable of degrading or assimilating the contaminant.
- According to an aspect of some embodiments of the present invention there is provided a method of depleting a molecule from a solution, comprising contacting the solution with the microfiber or microtube of some embodiments of the invention, wherein the molecule is capable of binding to or being processed by the cell, thereby depleting the molecule from the solution.
- According to an aspect of some embodiments of the present invention there is provided a method of isolating a molecule from a solution, comprising: (a) contacting the solution with the microfiber or microtube of some embodiments of the invention under conditions which allow binding of the molecule to the cell, and; (b) eluting the molecule from the microfiber or the microtube; thereby isolating the molecule from the solution.
- According to an aspect of some embodiments of the present invention there is provided a method of detecting a presence of a molecule in a sample, comprising: (a) contacting the sample with the microfiber or microtube of some embodiments of the invention, wherein the cell is capable of binding to or processing the molecule, and; (b) detecting the binding or the processing; thereby detecting the presence of the molecule in the sample.
- Water purification usually entails the removal of toxic chemicals such as mercury, mercurial compounds, and cadmium or elements such as toluene, chloroform, benzene, pesticides and herbicides. In one embodiment, said cell is Pseudomonads. In another embodiment, said Pseudomonads is used to degrade toluene, benzene, phenol, naphthalene, atrazine, and/or certain hydrocarbons from oil.
- In another embodiment, the microfibers or compositions comprising same are used in water systems for removal of toxic heavy metals such as cadmium and mercury. None limiting examples of bacterial strains useful for such application include Chromobacterium violaceum, Pseudomonas maltophila, Pseudomonas aeruginosa, Spirulina planensis, Staphylococcus aureus, Bacillus cereus, Bacillus subtilis and Escherichia coli.
- According to an aspect of some embodiments of the present invention there is provided a controlled release mechanism, such as that each layer of said microfiber or microtube provides a separate phase of sustained release.
- In another embodiment, the microfibers or compositions comprising same are used in fermentation methods.
- According to another aspect, there is provided a method for producing the microfibers or microtubes of the invention, the method comprising co-electrospinning three solutions through triple-axial capillaries.
- Reference is made to
FIG. 1 , illustrating a triple-axial capillary (e.g., a spinneret with three co-axial capillaries) used for the triple axial co-electrospining procedure for forming a concentric triple-layer electrospun microfiber or microtube of the invention. - According to some embodiments, there is provided a method for producing a concentric triple-layered microfiber, the method comprising providing a first polymeric solution for forming an exterior layer of the microfiber, a second polymeric solution for forming an intermediate layer of the microfiber, and a third solution for forming an interior layer or a core of the microfiber, said third solution comprises cells; and co-electrospinning the first polymeric solution, second polymeric solution and the third solution through a triple-axial capillaries, thereby producing the concentric triple-layered microfiber.
- According to some embodiments of the invention, the multi-layered microfiber or microtube comprises an exterior layer formed of a first polymeric solution, an intermediate layer formed of a second polymeric solution, and/or an interior layer formed of a third solution (a polymeric solution or a solution devoid of polymers).
- In another embodiment, said first polymeric solution solidifies faster than said second polymeric solution. In another embodiment, said second polymeric solution solidifies faster than said third polymeric solution.
- In some embodiments, the solvent selected for forming the exterior layer of the microfiber is an organic-based solvent and the solvent selected for forming the intermediate and/or internal layer of the microfiber is a solvent compatible for cell growth and viability.
- As used herein, an “organic solvent” relate to a chemical class of compounds that are used routinely in commercial industries, which typically share a common structure (at least 1 carbon atom and 1 hydrogen atom), low molecular weight, lipophilicity, and volatility, and they exist in liquid form at room temperature. In some embodiments, the organic solvents are aliphatic-chain compounds, such as n-hexane. In other embodiments, the organic solvents are aromatic compounds with a 6-carbon ring, such as benzene or xylene. Aliphatics and aromatics may contain a substituted halogen element and may be referred to as halogenated hydrocarbons, such as perchloroethylene (PCE or PER), trichloroethylene (TCE), and carbon tetrachloride. Alcohols, ketones, glycols, esters, ethers, aldehydes, and pyridines are substitutions for a hydrogen group.
- As used herein, a “solvent compatible for cell growth and viability” relates to a solvent which is substantially not-toxic for a cell. Non-limiting example of such solvents include water, glycerol-based solutions, and cell culture media.
- In another embodiment, a solvent of said second polymeric solution is incapable of dissolving said first polymeric solution. In another embodiment, a solvent of said third polymeric solution is incapable of dissolving said second polymeric solution. In another embodiment, the second polymeric solution and said third solution comprise the same solvent.
- As used herein the phrase “co-electrospinning” refers to a process in which at least three solutions (out of which at least two are polymeric solutions) are electrospun from co-axial capillaries (i.e., at least three capillary dispensers wherein one capillary is placed within an intermediate capillary which is placed within a third capillary while sharing a co-axial orientation) forming the spinneret. The capillary can be, for example, a syringe with a metal needle or a bath provided with one or more capillary apertures from which the polymeric solutions can be extruded, e.g., under the action of hydrostatic pressure, mechanical pressure, air pressure and/or high voltage.
- The collector serves for collecting the electrospun element (e.g., the electrospun microfiber) thereupon. Such a collector can be a rotating collector or a static (non-rotating) collector. When a rotating collector is used, such a collector may have a cylindrical shape (e.g., a drum), however, the rotating collector can be also of a planar geometry (e.g., an horizontal disk). The spinneret is typically connected to a source of high voltage, such as of positive polarity, while the collector is grounded, thus forming an electrostatic field between the dispensing capillary (dispenser) and the collector. Alternatively, the spinneret can be grounded while the collector is connected to a source of high voltage, such as with negative polarity. As will be appreciated by one ordinarily skilled in the art, any of the above configurations establishes motion of a positively charged jet from the spinneret to the collector. Reverse polarity for establishing motions of a negatively charged jet from the spinneret to the collector are also contemplated.
- For electrospinning, the first polymeric solution is injected into the outer capillary of the co-axial capillaries, the second polymeric solution is injected into the intermediate capillary of the co-axial capillaries, while the third solution is injected into the inner capillary of the co-axial capillaries. In one embodiment, such as in order to form a microtube (i.e., a hollow structure), the first polymeric solution (which is for forming the exterior layer of the microfiber) solidifies faster than the second polymeric solution (for forming the middle/intermediate layer of the microfiber), which in turn, solidifies faster than the third polymeric solution (for forming the interior layer of the microfiber). In another embodiment, the third polymeric solution (for forming the interior layer) is not a polymeric solution. In one embodiment, the interior layer is formed by electrospinning a suspension of cells and/or molecules of interest.
- In another embodiment, the formation of a microfiber also requires that the solvent of the second polymeric solution be incapable of dissolving the first polymeric solution. In another embodiment, the solvent of the third polymeric solution is similar or identical to the solvent of the second polymeric solution In another embodiment, the solvent of the third polymeric solution be incapable of dissolving the second polymeric solution. The solidification rates of the first, second and third polymeric solutions may be critical for forming the microfiber. For example, for a microtube of about 100 the solidification of the first polymer (of the first polymeric solution) can be within about 30 milliseconds (ms), the solidification of the second polymer (of the second polymeric solution) can be within about 10-20 seconds, while the solidification of the third polymer (of the third polymeric solution) can be substantially longer than the second polymer. The solidification may be a result of polymerization rate and/or evaporation rate.
- As used herein the phrase “polymeric solution” refers to a soluble polymer, i.e., a liquid medium containing one or more polymers, co-polymers or blends of polymers dissolved in a solvent or mixture of solvents. The polymer used by the invention can be a natural, synthetic, biocompatible and/or biodegradable polymer. 15
- The phrase “synthetic polymer” refers to polymers that are not found in nature, even if the polymers are made from naturally occurring biomaterials. Examples include, but are not limited to, aliphatic polyesters, poly(amino acids), copoly(ether-esters), polyalkylenes, oxalates, polyamides, tyrosine derived polycarbonates, poly(iminocarbonates), polyorthoesters, polyoxaesters, polyamidoesters, polyoxaesters containing amine groups, poly(anhydrides), polyphosphazenes, and combinations thereof.
- Suitable synthetic polymers for use by the invention can also include biosynthetic polymers based on sequences found in naturally occurring proteins such as those of collagen, elastin, thrombin, fibronectin, or mutant or synthetic derivatives thereof or, starches, poly(amino acids), poly(propylene fumarate), gelatin, alginate, pectin, fibrin, oxidized cellulose, chitin, chitosan, tropoelastin, hyaluronic acid, polyethylene, polyethylene terephthalate, poly(tetrafluoroethylene), polycarbonate, polypropylene and poly(vinyl alcohol), ribonucleic acids, deoxyribonucleic acids, polypeptides, proteins, polysaccharides, polynucleotides and combinations thereof.
- The phrase “natural polymer” refers to polymers that are naturally occurring. Non-limiting examples of such polymers include, silk, collagen-based materials, chitosan, hyaluronic acid, albumin, fibrinogen, and alginate.
- As used herein, the phrase “co-polymer” refers to a polymer of at least two chemically distinct monomers. Non-limiting examples of co-polymers include, polylactic acid (PLA)-polyethyleneglycol (PEG), polyethylene glycol terephthalate (PEGT)/polybutylene terephthalate (PBT), PLA-polyglycolic acid (PGA), PEG-polycaprolactone (PCL) and PCL-PLA.
- As used herein, the phrase “blends of polymers” refers to the result of mixing two or more polymers together to create a new solution/composition with different physical properties.
- The phrase “biocompatible polymer” refers to any polymer (synthetic or natural) which when in contact with cells, tissues or body fluid of an organism does not induce adverse effects such as immunological reactions and/or rejections, cellular death, and the like. A biocompatible polymer can also be a biodegradable polymer.
- According to some embodiments of the invention, the first, the second and/or the third polymeric solutions are biocompatible.
- Non-limiting examples of biocompatible polymers include polyesters (PE), PCL, PLA, PGA, PEG, polyvinyl alcohol, polyvinyl pyrrolidone, polytetrafluoroethylene (PTFE, teflon), polypropylene (PP), polyvinylchloride (PVC), polymethylmethacrylate (PMMA), polyamides, segmented polyurethane, polycarbonate-urethane and thermoplastic polyether urethane, silicone-polyether-urethane, silicone-polycarbonate-urethane collagen, PEG-DMA, alginate, hydroxyapatite and chitosan, blends and copolymers thereof.
- The phrase “biodegradable polymer” refers to a synthetic or natural polymer which can be degraded (i.e., broken down) in a physiological environment such as by proteases or other enzymes produced by living organisms such as bacteria, fungi, plants and animals. Biodegradability depends on the availability of degradation substrates (i.e., biological materials or portion thereof which are part of the polymer), the presence of biodegrading materials (e.g., microorganisms, enzymes, proteins) and the availability of oxygen (for aerobic organisms, microorganisms or portions thereof), lack of oxygen (for anaerobic organisms, microorganisms or portions thereof) and/or other nutrients.
- Examples of biodegradable polymers/materials include, but are not limited to, collagen (e.g., collagen I or IV), fibrin, hyaluronic acid, polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyethyleneglycol (PEG), collagen, PEG-DMA, alginate, chitosan copolymers or mixtures thereof.
- According to some embodiments, the polymeric solution can be made of one or more polymers, each can be a polymer or a co-polymer such as described hereinabove.
- According to some embodiments of the invention, the polymeric solution is a mixture of at least one biocompatible polymer and a co-polymer (either biodegradable or non-biodegradable).
- For certain applications one or more layers of the microfiber may comprise pores, thus creating a “breathing” tube. Methods of forming “breathing” microtube (i.e., microtubes with pores in the shell thereof) are described in PCT/IB2007/054001 to Zussman E., et al., which is fully incorporated herein by reference. Briefly, “breathing” fibers and/or tubes can be formed by the inclusion of a high percent (e.g., at least 80%) of a volatile component such as tetrahydrofuran (THF), chloroform, acetone, or trifluoroefhanol (TFE) in the first polymeric solution, and/or by the inclusion of a water-soluble polymer such as polyethylene glycol (PEG) in the first polymeric solution so that the first polymeric solution comprises a blend of polymers in which one is water-soluble and the other is water-insoluble (e.g., a blend of PEG and PCL).
- Alternatively, “breathing” microtubes can be formed by inducing pores in one or more layers of the microfiber, after the completion of the electrospinning process, essentially as described in PCT WO 2006/106506, which is fully incorporated herein by reference, such as by passing an electrical spark or a heated puncturing element through the electrospun microfiber, or by using a pulsed or continuous laser beam through the electrospun microfiber.
- According to some embodiments of the invention, the first polymeric solution comprises PEG for inducing pores in the exterior layer of the microfiber. For example, to generate pores greater (>) than 150 nm in diameter, the first polymeric solution may include about 4% PEG MW 35 kDa. Similarly, to generate pores smaller (<) 150 nm in diameter, the first polymeric solution may include about 2% PEG MW 6 kDa or less.
- The microfiber can be designed for selective passage of certain molecules or particles. The passage through the exterior layer pores depends on the size and/or the electrical charge of the molecules/particles with respect to the geometry (length and radius), surface energy, electrical charge of the shell pores, and the viscosity and surface tension of the liquid containing the molecules/particles.
- According to some embodiments of the invention, the porosity (i.e., the ratio of the volume of the pores to the volume of the mass) and pore size can control the release of the cell/
molecules 30 from the microfiber. For example, a layer with pores larger than 1 μm in diameter (e.g., about 1-2 μm) can enable the release of a cell therethrough. In addition, increased porosity can result in a greater rate of release through the pores. - Alternatively, the microfiber can be made such that it prevents diffusion or passage of the cell, or any molecule therethrough (e.g., substantially devoid of pores, or with pores having a diameter which is smaller than the cell, or which exhibit a geometry which prevents passage of cells or membrane-coated particles therethrough).
- Generally, the nomenclature used herein and the laboratory procedures utilized in the present invention include molecular, biochemical, microbiological and
recombinant DNA 10 techniques. Such techniques are thoroughly explained in the literature. See, for example, “Molecular Cloning: A laboratory Manual” Sambrook et al., (1989); “Current Protocols in Molecular Biology” Volumes I-III Ausubel, R. M., ed. (1994); Ausubel et al., “Current Protocols in Molecular Biology”, John Wiley and Sons, Baltimore, Md. (1989); Perbal, “A Practical Guide to Molecular Cloning”, John Wiley & Sons, New York (1988); Watson et al., “Recombinant DNA”, Scientific American Books, New York; Birren et al. (eds) “Genome Analysis: A Laboratory Manual Series”, Vols. 1-4, Cold Spring Harbor Laboratory Press, New York (1998); methodologies as set forth in U.S. Pat. Nos. 4,666,828; 4,683,202; 4,801,531; 5,192,659 and 5,272,057; “Cell Biology: A Laboratory Handbook”, Volumes I-III Cellis, J. E., ed. (1994); “Culture of Animal Cells—A Manual of Basic Technique” by Freshney, Wiley-Liss, N. Y. (1994), Third Edition; “Current Protocols in Immunology” Volumes I-III Coligan J. E., ed. (1994); Stites et al. (eds), “Basic and Clinical Immunology” (8th Edition), Appleton & Lange, Norwalk, Conn. (1994); Mishell and Shiigi (eds), “Selected Methods in Cellular Immunology”, W. H. Freeman and Co., New York (1980); available immunoassays are extensively described in the patent and scientific literature, see, for example, U.S. Pat. Nos. 3,791,932; 3,839,153; 3,850,752; 3,850,578; 3,853,987; 3,867,517; 3,879,262; 3,901,654; 3,935,074; 3,984,533; 3,996,345; 4,034,074; 4,098,876; 4,879,219; 5,011,771 and 5,281,521; “Oligonucleotide Synthesis” Gait, M. J., ed. (1984); “Nucleic Acid Hybridization” Hames, B. D., and Higgins S. J., eds. (1985); “Transcription and Translation” Hames, B. D., and Higgins S. J., eds. (1984); “Animal Cell Culture” Freshney, R. I., ed. (1986); “Immobilized Cells and Enzymes” IRL Press, (1986); “A Practical Guide to Molecular Cloning” Perbal, B., (1984) and “Methods in Enzymology” Vol. 1-317, Academic Press; “PCR Protocols: A Guide To Methods And Applications”, Academic Press, San Diego, Calif. (1990); Marshak et al., “Strategies for Protein Purification and Characterization—A Laboratory Course Manual” CSHL Press (1996); all of which are incorporated by reference. Other general references are provided throughout this document. - The polymers PVDF-HFP (Mw=400,000 Da), PVP (Mw=1,300,000 Da) and PEG (Mw=6000 Da) and the solvents Dimethylforamide (DMF) and tetrahydrofuran (THF) were purchased from Sigma and were used without further purification. Glycerol was purchased from BioLab and was sterilized before use. De-ionized water with conductivity of <19 uS was used for aqueous solutions. Solutions for electrospinning were prepared by simple mixing for several hours. All experiments were conducted at room temperature and a relative humidity of 50-60%. The flow rates of all solutions were controlled by syringe pumps.
- Table 1, represents different compositions used for fabricating the electrospun fibers using tri-axial spinnerets.
-
TABLE 1 Fibers compositions Internal Shell Intermediate layer layer/core 15% PVDF-HFP in DMF:THF in 15% PVP in water Yeast in water DMF:THF (1:2 v/v) + 2% PEG (150 mg/ml) 15% PVDF-HFP in DMF:THF in 15% PVP in water Yeast in water DMF:THF (1:2 v/v) + 4% PEG (150 mg/ml) 15% PVDF-HFP in DMF:THF in 15% PVP in water Yeast in water DMF:THF (1:2 v/v) + 6% PEG (150 mg/ml) 15% PVDF-HFP in DMF:THF in 15% PVP in water Yeast in water DMF:THF (1:2 v/v) + 8% PEG (150 mg/ml) - Encapsulation of yeast in fibers was successfully achieved using all compositions and spinning parameters given in the table above. The encapsulated yeast remained alive, active and proliferated inside the fibers utilizing the internal space of the fiber/tube and expand until full space was occupied with a densely packed cells.
- Use of the tri-axial spinneret enabled to introduce a larger amount of cells (about 10 times more) during the electrospinning process. This shortened the period of the post spinning recovery period and the fibers were subjected to the actual medium sooner.
- Descriptions of embodiments of the invention in the present application are provided by way of example and are not intended to limit the scope of the invention. The described embodiments comprise different features, not all of which are required in all embodiments of the invention. Some embodiments utilize only some of the features or possible combinations of the features. Variations of embodiments of the invention that are described, and embodiments of the invention comprising different combinations of features noted in the described embodiments, will occur to persons of the art. The scope of the invention is limited only by the claims.
Claims (29)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/558,238 US20180044817A1 (en) | 2015-03-17 | 2016-03-17 | Multi-layered microfibers and use thereof |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562134364P | 2015-03-17 | 2015-03-17 | |
US15/558,238 US20180044817A1 (en) | 2015-03-17 | 2016-03-17 | Multi-layered microfibers and use thereof |
PCT/IL2016/050297 WO2016147192A1 (en) | 2015-03-17 | 2016-03-17 | Multi-layered microfibers and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
US20180044817A1 true US20180044817A1 (en) | 2018-02-15 |
Family
ID=56918461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/558,238 Pending US20180044817A1 (en) | 2015-03-17 | 2016-03-17 | Multi-layered microfibers and use thereof |
Country Status (3)
Country | Link |
---|---|
US (1) | US20180044817A1 (en) |
EP (1) | EP3271502A4 (en) |
WO (1) | WO2016147192A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220049376A1 (en) * | 2020-08-13 | 2022-02-17 | Gelatex Technologies OÜ | Device and method for producing polymer fibers and its uses thereof |
CN115012125A (en) * | 2022-07-29 | 2022-09-06 | 韩忠 | Moisture-absorbing and quick-drying polyester fabric and preparation method thereof |
US20220409769A1 (en) * | 2019-09-17 | 2022-12-29 | Mayo Foundation For Medical Education And Research | Methods and materials for treating fistulas |
WO2023135598A1 (en) * | 2022-01-11 | 2023-07-20 | Nanospun Technologies Ltd. | Artificial skin comprising fibrous mat |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106676653B (en) * | 2016-11-21 | 2019-05-24 | 上海理工大学 | Core fluid carries two kinds of three-level coaxial electrically spun methods that can not spin outer sheath fluid |
KR102223311B1 (en) * | 2018-04-26 | 2021-03-04 | 인하대학교 산학협력단 | Spirulina extract-impregnated alginate-PCL nanofiber wound dressing |
CN109137123B (en) * | 2018-08-14 | 2020-12-22 | 郑州大学 | Method for preparing polycarbazole derivative nanofiber |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070009736A1 (en) * | 2005-07-11 | 2007-01-11 | Industrial Technology Research Institute | Nanofiber and method for fabricating the same |
US20110028834A1 (en) * | 2008-02-21 | 2011-02-03 | Technion Research & Development Foundation Ltd. | Use of electrospun microtubes for drug delivery |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014160045A1 (en) * | 2013-03-14 | 2014-10-02 | Cornell University | Electrospinning apparatuses & processes |
CN103668485B (en) * | 2013-12-03 | 2016-03-16 | 大连海洋大学 | The Electrospun nano-fibers film of coaxial three floor height activity embedding biology enzymes and preparation method |
-
2016
- 2016-03-17 EP EP16764350.1A patent/EP3271502A4/en active Pending
- 2016-03-17 WO PCT/IL2016/050297 patent/WO2016147192A1/en active Application Filing
- 2016-03-17 US US15/558,238 patent/US20180044817A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070009736A1 (en) * | 2005-07-11 | 2007-01-11 | Industrial Technology Research Institute | Nanofiber and method for fabricating the same |
US20110028834A1 (en) * | 2008-02-21 | 2011-02-03 | Technion Research & Development Foundation Ltd. | Use of electrospun microtubes for drug delivery |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220409769A1 (en) * | 2019-09-17 | 2022-12-29 | Mayo Foundation For Medical Education And Research | Methods and materials for treating fistulas |
US20220049376A1 (en) * | 2020-08-13 | 2022-02-17 | Gelatex Technologies OÜ | Device and method for producing polymer fibers and its uses thereof |
US11697892B2 (en) * | 2020-08-13 | 2023-07-11 | Gelatex Technologies OÜ | Device and method for producing polymer fibers and its uses thereof |
WO2023135598A1 (en) * | 2022-01-11 | 2023-07-20 | Nanospun Technologies Ltd. | Artificial skin comprising fibrous mat |
CN115012125A (en) * | 2022-07-29 | 2022-09-06 | 韩忠 | Moisture-absorbing and quick-drying polyester fabric and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
EP3271502A4 (en) | 2019-01-02 |
EP3271502A1 (en) | 2018-01-24 |
WO2016147192A1 (en) | 2016-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20180044817A1 (en) | Multi-layered microfibers and use thereof | |
US20200087649A1 (en) | Method of attaching a cell-of-interest to a microtube | |
AU2007303821B2 (en) | Microtubes and methods of producing same | |
US9476149B2 (en) | Methods for electrospinning hydrophobic coaxial fibers into superhydrophobic and oleophobic coaxial fiber mats | |
US20130196405A1 (en) | Porous fiber, methods of making the same and uses thereof | |
Klein et al. | Encapsulation of Pseudomonas sp. ADP cells in electrospun microtubes for atrazine bioremediation | |
Wang et al. | Nanofibres and their influence on cells for tissue regeneration | |
KR101056982B1 (en) | Porous fiber, porous fiber structure, and manufacturing method thereof | |
Padaki et al. | Electrospun nanofibers: role of nanofibers in water remediation and effect of experimental variables on their nano topography and application processes | |
JP2010188426A (en) | Cleaning sheet | |
TWI508836B (en) | An electrospinning apparatus with a sideway motion device and a method of using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: NANOSPUN TECHNOLOGIES LTD., ISRAEL Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BEN DROR, OHAD;REEL/FRAME:055673/0684 Effective date: 20210321 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
AS | Assignment |
Owner name: NANOSPUN TECHNOLOGIES LTD., ISRAEL Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DROR, YAEL;REEL/FRAME:060988/0024 Effective date: 20220905 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |